C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2004
11/02/2004	US6811988 Compositions and methods for diagnosing Alzheimer's disease
11/02/2004	US6811972 For preparing a hybridoma cell line which specifically recognizes and binds tumor associated antigen; antibodies; prostate carcinoma tumor antigen gene-1
11/02/2004	US6811970 Measurement of dimerization of viral polymerase; obtain sample containing viral dimerized proteins, incubate with binding agent, determine the amount of complex formed
11/02/2004	US6811785 Multivalent MHC class II—peptide chimeras
11/02/2004	US6811782 Peptide composition as immunogen for the treatment of allergy
11/02/2004	US6811780 Concurrent administering of cytokine antagonist and vaccine
11/02/2004	US6811779 Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
11/02/2004	US6811773 Human monocyte colony inhibitory factor (M-CIF) polypeptides
11/02/2004	CA2138921C Method of producing a concentrate of anti-d immunoglobulin g and pharmaceutical preparation which contains it
11/02/2004	CA1341463C Cyclosporin a derivatives modified at position 1 and fluorescence polarization assay for cyclosporin a and metabolites
10/2004
10/28/2004	WO2004092404A2 Inhibitors of acidic mammalian chitinase as asthma therapeutics
10/28/2004	WO2004092393A1 Purification of polypeptides
10/28/2004	WO2004092384A2 Means and methods for diagnosing and treating affective disorders
10/28/2004	WO2004092360A2 The severe acute respiratory syndrome coronavirus
10/28/2004	WO2004092353A2 Surface receptor complexes as biomarkers
10/28/2004	WO2004092343A2 Epha2, hypoproliferative cell disorders and epithelial and endothelial reconstitution
10/28/2004	WO2004092332A2 Sars virus polypeptides
10/28/2004	WO2004092220A1 Methods for ex vivo hybridoma-free production of polyclonal and monoclonal antibodies and generation of immortalized cell populations
10/28/2004	WO2004092219A2 Alteration of fcrn binding affinities or serum half-lives of antibodies by mutagenesis
10/28/2004	WO2004092215A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
10/28/2004	WO2004092208A2 Sars-related proteins
10/28/2004	WO2004091657A2 Therapy of autoimmune disease in a patient with an inadequate response to a tnf-alpha inhibitor
10/28/2004	WO2004091655A2 Immunogenic recombinant antibody
10/28/2004	WO2004091543A2 Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
10/28/2004	WO2004091519A2 Methods of preventing or treating respiratory conditions
10/28/2004	WO2004091511A2 Compositions and methods to diagnose and treat lung cancer
10/28/2004	WO2004091510A2 Recombinant il-9 antibodies and uses thereof
10/28/2004	WO2004091491A2 Profiling conformational variants, antibody compositions and methods of using the same
10/28/2004	WO2004091384A2 Erbb surface receptor complexes as biomarkers
10/28/2004	WO2004091379A2 Assessing neuronal damage from blood samples
10/28/2004	WO2004091375A2 Epha2 and non-neoplastic hyperproliferative cell disorders
10/28/2004	WO2004076618A3 Genetically modified non-human mammals and cells
10/28/2004	WO2004046306A3 Fully human antibody fab fragments with human interferon-gamma neutralizing activity
10/28/2004	WO2004045520A3 Complement receptor 2 targeted complement modulators
10/28/2004	WO2004037205A3 LOW DOSE METHODS FOR TREATING DISORDERS IN WHICH TNFα ACTIVITY IS DETRIMENTAL
10/28/2004	WO2004029207A3 Optimized fc variants and methods for their generation
10/28/2004	WO2004024748A3 High affinity monoclonal antibody for recognizing the progesterone receptor (pr) and method for creating the antibody
10/28/2004	WO2004024075A3 Chemokine receptor antagonists as therapeutic agents
10/28/2004	WO2004018660A3 Novel lipases and uses thereof
10/28/2004	WO2004012817A3 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs
10/28/2004	WO2004009777A3 Compositions and methods to select dendritic cells from a heterogeneous cell population
10/28/2004	WO2004005349A3 Preparation based on an antibody directed against a tumor-associated glycosylation such as lewis structures
10/28/2004	WO2004003157A3 Gene regulation in transgenic animals using a transposon-based vector
10/28/2004	WO2003105782A3 Specificity grafting of a murine antibody onto a human framework
10/28/2004	WO2003100005A3 Universal chimera bank
10/28/2004	WO2003057827A3 Insulin-responsive dna binding protein-1 and methods to regulate insulin-responsive genes
10/28/2004	WO2003030833A3 Angiopoietin-2 specific binding agents
10/28/2004	WO2003022882A3 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
10/28/2004	WO2003020954A3 205p1b5 in treatment and detection of cancer
10/28/2004	WO2002088322A3 Cell adhesion and extracellular matrix proteins
10/28/2004	WO2001081540A3 Growth factor which acts through erb b-4 rtk
10/28/2004	US20040216180 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same
10/28/2004	US20040214999 Novel compounds for chemiluminescense procedures
10/28/2004	US20040214996 Multimeric peptides/immunoglobulins for use in the treatment of bone disorders
10/28/2004	US20040214995 Melanoma antigens and their use in diagnostic and therapeutic methods
10/28/2004	US20040214994 Genetically engineered immunoglobulin specific for hepatitis helicase for use in prevention and treatment of infection; immunotherapy
10/28/2004	US20040214993 Monoclonal antibody for use in prevention and treatment of cell proliferative disorders; immunotherapy; antitumor agents
10/28/2004	US20040214990 Transmembrane protein differentially expressed in cancer
10/28/2004	US20040214788 by administering an antagonist against one or more of the vitamin binding proteins riboflavin carrier protein, retinol binding protein, and folic acid binding protein
10/28/2004	US20040214771 Cleaved serum response factor in cardiac diagnosis and therapy
10/28/2004	US20040214764 inhibiting viral replication or infection by contacting a composition with a virally infected cell with a cell impervious cephalin-binding ligand or proteins; treating an animal with a viral infection; hepatitis, influenza, AIDS, viral pneumonia or respiratory disease
10/28/2004	US20040214761 induction of apoptosis in tumor cells by administering monoclonal antibodies
10/28/2004	US20040214349 Molecular marker
10/28/2004	US20040214331 Transforming and propagating viral-like particle in cells; for use as tools in prevention and treatment of viral infection; viricides and genetic vaccines
10/28/2004	US20040214318 Viral expression vector comprising enhancing regulatory sequences for use as heterologous gene transfer and expression tool; in vitro transcription/translation systems
10/28/2004	US20040214289 Using variations in osmolarity and temperature to control generation of non-glycosylated heavy chain immunoglobulins in chinese hamster ovaries
10/28/2004	US20040214288 Methods of generating high-production of antibodies from hybridomas created by in vitro immunization
10/28/2004	US20040214286 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy
10/28/2004	US20040214283 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
10/28/2004	US20040214277 Methods and compositions for polypeptide engineering
10/28/2004	US20040214275 Von willebrand factor (vmf)-cleaving enzyme
10/28/2004	US20040214269 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004	US20040214268 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004	US20040214267 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004	US20040214265 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004	US20040214251 Immunogenic label for detection of low concentrations of viral therapeutics/antibodies in blood; diagnosing/detecion/monitoring viral drug resistance; immunoassay
10/28/2004	US20040214247 Comprises immunoglobulin which binds to tumor specific epitope and inhibits binding of matrix protein/collagen/gelatin complexes; immunotherapy and antitumor agents
10/28/2004	US20040214246 Monoclonal antibodies specific to pro-prostate specific antigen (PROPSA) for use as component of bioassy for detection of cancer
10/28/2004	US20040214245 Diagnostic and therapeutic use of antibodies against the urokinase receptor
10/28/2004	US20040214235 Immunoglobulin specific to tumor necrosis factor -related apoptosis-inducing ligand (TRAIL) for use in the prevention and treatment of cancer; immnotherapy
10/28/2004	US20040214230 Monoclonal antibody which binds galanin-lke peptides for use in diagnosis, prevention and treatment of obesity, sterility, collagen or rheumatic disease
10/28/2004	US20040214229 Amino acid sequences for use in diagnosis, prevention and treatment of sepsis and infections
10/28/2004	US20040214214 Nucleotide sequences coding obesity polypeptide for use in the diagnosis and treatment of viral, cell proliferative weight control and eating disorders
10/28/2004	US20040214190 Mammalian c-type lectins
10/28/2004	US20040214187 Nucleotide sequences coding immunoglobulin orphan receptor (OXR) for use in identifying modulators for treatment of atherosclerosis, arthritis, multiple sclerosis, thrombosis, graft rejection and graft versus host disease
10/28/2004	US20040214171 Cat kidney disease marker
10/28/2004	US20040214165 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
10/28/2004	US20040213808 immunogenic compositions containing as active ingredients recombinantly-produced forms of truncated flavivirus envelope and non-structural glycoproteins; may also include an adjuvant, such as saponin or a saponin-like material
10/28/2004	US20040213804 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an N-acryloylated polysaccharide
10/28/2004	US20040213803 a polypeptide conjugated to a Streptococcus pneumoniae capsular polysaccharide; an expression vector encoding a Streptococcus pneumoniae pneumolysin polypeptide that lacks hemolytic activity; vaccine; genetic vaccine; antigen
10/28/2004	US20040213802 Gene of novel corynebacterium diphtheriae antigen
10/28/2004	US20040213801 targets particular molecules that occur at the cell surface of HIV during viral entry into host cells; humoral response generated in vivo as a prophylactic measure in individuals to reduce or inhibit the ability of HIV to infect uninfected cells; mechanism of HIV cell entry
10/28/2004	US20040213800 Active immunization to generate antibodies to soluble A-beta
10/28/2004	US20040213796 Immunotherapy for chronic myelocytic leukemia
10/28/2004	US20040213795 agonists and/or antagonists of PD-1 (Programmed Death 1) thereby modulate immune responses; treating autoimmune diseases, inflammatory disorders, allergies, transplant rejection, cancer
10/28/2004	US20040213793 nucleic acid molecule encoding a transmembrane TEM1; Inhibiting neoangiogenesis by administering a molecule with an antibody variable region which specifically binds to an extracellular domain of a Tumor Endothelial Markers (TEMs) protein; polycystic kidney disease; psoriasis
10/28/2004	US20040213791 Monoclonal antibodies; for diagnosis and treatment of prostate cell proliferative disorders; immunogens; immunotherapy; cell lines
10/28/2004	US20040213790 VEGF-related protein
10/28/2004	US20040213789 Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
10/28/2004	US20040213788 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders

1 ... 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 ... 1494